News
Phase II Studie mit AIC316 zur Behandlung von genitalem Herpes...
www.pressebox.de
AiCuris GmbH & Co. KG, Wie AiCuris heute bekannt gab, hat der letzte Teilnehmer die Phase II Studie
AiCuris Completes Phase II Genital Herpes Trial with AIC316 Ahead of...
www.bionity.com
AiCuris announced that the last subject has completed their Phase-II trial
AiCuris Completes Phase II Genital Herpes Trial with AIC316 Ahead of...
www.technologynetworks.com
Trial aimed to investigate different doses of a new antiviral drug in subjects with genital HSV Type 2 infection.
AiCuris Completes Phase II Genital Herpes Trial with AIC316 Ahead of...
www.b3cnewswire.com
AiCuris announced today that the last subject has completed their Phase-II trial A double-blind randomized placebo controlled dose-finding trial to investigate...
sortiert nach Relevanz / Datum